Objective: We aimed to study the long-term development of health-related quality of life (HR-QoL) in patients with peripheral arterial disease after they underwent peripheral bypass surgery and to evaluate the influence of adverse vascular events that occurred during follow-up. Methods: We compared current HR-QoL scores with previous measurements in patients who participated in the Dutch Bypass and Oral Anticoagulants or Aspirin (BOA) Study between 1995 and 1998 after they underwent infrainguinal bypass surgery. Patients from six centers that contributed most to the Dutch BOA Study (n ‫؍‬ 482) were followed up retrospectively from 1995 up to 2009. Results: At a mean follow-up of 11 years since BOA randomization, 165 of the 482 patients were alive of whom 123 (75%) completed the EQ-5D and RAND-36 questionnaires. Fifty-three patients completed the questionnaires three times: at BOA entry, at BOA close-out, and at BOA long-term follow-up. In these patients the HR-QoL scores decreased over time, especially for the physical health dimension. In comparison with the general population, matched for age and gender, the HR-QoL scores at both BOA entry and long-term follow-up were substantially lower, even if the patient's graft was patent and no other vascular events had occurred. The occurrence of an adverse vascular event worsened the physical health state further. Generally, peripheral bypass surgery is performed to improve walking distance, diminish symptoms of intermittent claudication, or increase limb salvage in case of critical limb ischemia, a grave condition of peripheral arterial disease (PAD).
Generally, peripheral bypass surgery is performed to improve walking distance, diminish symptoms of intermittent claudication, or increase limb salvage in case of critical limb ischemia, a grave condition of peripheral arterial disease (PAD). 1 In clinical practice, important outcome measures of bypass surgery are the technical and clinical success rates. For patients, treatment success is merely determined by their perception of change in physical, psychological, and social well-being after revascularization. Indeed, clinically successful bypass surgery was found to significantly improve the health-related quality of life (HR-QoL) in patients with critical limb ischemia up to 1 year after intervention, 2 whereas symptomatic graft-related events, lower limb amputation, and ischemic events that occurred within 21 months or less after revascularization reduced the HR-QoL substantially. 2, 3 Besides lower limb amputation, patients with PAD are also at high risk of myocardial infarction, stroke, and major bleeding. 4, 5 To determine the long-term HR-QoL after peripheral bypass surgery, we assessed the present HR-QoL in PAD patients who underwent peripheral bypass surgery between 1995 and 1998. These results were compared with HR-QoL scores obtained no longer than 2 years after bypass surgery. Our second aim was to evaluate the influence of adverse vascular events that occurred after peripheral bypass surgery on the HR-QoL at long-term follow-up.
METHODS
Study population. The present study population was based on the Dutch Bypass and Oral Anticoagulants or Aspirin (BOA) Study. 6 This multicenter randomized trial compared the effects of treatment with oral anticoagulants or aspirin on preventing bypass occlusion and ischemic complications in patients who underwent infrainguinal bypass surgery. Full details of the Dutch BOA Study have been published elsewhere. 6 We conducted a retrospective long-term follow-up of the Dutch BOA Study. A sample of 482 patients from six centers that contributed the largest number of patients to the Dutch BOA Study was followed-up from 1995 to 2009. This sample size was based on the primary outcome event rate of the Dutch BOA Study. At an extended follow-up, we expected over 50% of the 482 patients to have experienced a primary outcome event allowing for the development of valid prediction models for an additional study. At the time of our approach between 2005 and 2009 for data collection, 165 of the 482 patients were still alive and included in the present study on HR-QoL. Their scores were set off against HR-QoL scores obtained earlier, between November 1995 and April 1998 over a mean follow-up of 26 months (range, 1 day to 45 months), in 1001 patients from the Dutch BOA Study. 3 All patients who participated in the Dutch BOA Study and the present study gave written informed consent.
HR-QoL assessment. All 165 patients were sent the EuroQoL 5 Dimensions (EQ-5D) and the RAND-36 questionnaires by postal mail. Nonresponders were sent a reminder or were contacted by telephone. Incomplete questionnaires were returned to the patients for completion. If necessary, the missing questions or questionnaires of participants who required help were completed by telephone call.
The EQ-5D 7 and the RAND-36 8,9 measure the generic quality of life and are designed for self-completion by the respondent. Both are valid and reliable questionnaires, 10 -15 and have shown to be suitable for perceived health assessment in patients with PAD. 16 -21 The EQ-5D consists of five dimensions concerning mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. 7, 22 Each dimension has three levels: (1) no problems; (2) some or moderate problems; and (3) extreme problems. The combination of each selected level per dimension results in a unique EQ-5D health state, which refers to a weighted health state index that ranges from 0.0 (death) to 1.0 (perfect health) developed by the EuroQol Group itself. 7, 22 In addition, the EQ-5D includes the Visual Analogue Scale (VAS), which records the selfrelated health status on a vertical graduated scale from 0 (worst imaginable health state) to 100 (best imaginable health state).
The RAND-36 consists of 36 questions with standardized response choices 8, 9 and refers to eight health dimensions: physical functioning, role of limitations due to physical health problems, bodily pain, general health perceptions, vitality, social functioning, role of limitations due to emotional problems, and mental health. Each dimension is represented on a scale from 0 to 100, with a high score defining a favorable health state. The scores of the first four and last four scales are aggregated into a physical and a mental component summary score, respectively.
Collection of outcome events. The long-term follow-up data of the 482 selected patients were collected retrospectively from the last patient visit of the Dutch BOA Study in April 1998 until August 2009 in a stepwise manner. The patient, the patient's attending vascular surgeon, and the patient's general practitioner were contacted to obtain information on outcome events. In case the patient was deceased, relatives or acquaintances were approached for follow-up data. The municipality register was queried about the last known residence if the patient had moved. If the patient, the patient's relatives, or acquaintances did not respond, the registry office was contacted to inform whether the patient was deceased and when. Data on outcome events, which occurred during the Dutch BOA Study between 1995 and 1998, had already been collected prospectively at follow-up visits at 3 and 6 months after bypass surgery and every 6 months thereafter until April 1998.
Registered outcome events were primary bypass occlusion, nonfatal myocardial infarction, nonfatal ischemic stroke, major amputation, minor and major bleeding, and death. The definition of each ischemic outcome event has been published in full detail elsewhere. 6 The definition of major bleeding corresponded with the criteria of the International Society on Thrombosis and Haemostasis, 23 and has also been published in full detail elsewhere. 24 Each recorded outcome event was adjudicated and classified by a panel consisting of a vascular surgeon, a clinical epidemiologist, a neurologist, and a cardiologist from the University Medical Center Utrecht, The Netherlands. Each specialist adjudicated and classified each outcome event individually. Any discrepancy was resolved plenary by discussion and documented in a logbook to ensure consistent adjudication and classification of new outcome events.
Data analysis. Descriptive statistics were used to compare patient characteristics between responders and nonresponders at follow-up. Differences in characteristics with a dichotomous outcome were reported as relative risks with corresponding 95% confidence intervals (95% CIs) and concomitant P values. Characteristics with a continuous outcome were reported as mean differences with 95% CIs and concomitant P values, which were derived from an independent samples two-sided Student t-test.
The short-term HR-QoL scores obtained at BOA inclusion and the long-term HR-QoL scores obtained at BOA follow-up were described as means with a standard deviation (SD) and compared with the norm HR-QoL scores of the Dutch population 9,25 at the same age or gender. In 1992, the normative data for the RAND-36 were collected from 1063 Dutch respondents with an age of 18 years or older. 9 Repeated measurements at 2 or at 6 months in a random sample showed a sufficient external validity of their results. Between April 2000 and January 2002, 9685 Dutch respondents aged 18 years or older filled out the EQ-5D questionnaire every 3 months within 1 year. 25 These figures were weighted for gender, age, and urbanization to make them representative of the Dutch population. Comparisons with the HR-QoL scores of the Dutch population were reported as mean differences with corresponding 95% CI only without concomitant P values as we could not provide precise P values but only crude estimations, because we do not have the raw data of the Dutch population in question.
Further, the long-term HR-QoL scores were compared between patients with and without adverse vascular events. Differences were reported as mean differences with corresponding 95% CI and concomitant P values derived from an independent samples two-sided Student t-test.
Finally, a separate comparison was done for HR-QoL scores that were obtained thrice in the same patient; first at BOA inclusion, then at the last patient visit in BOA, and finally at long-term follow-up between 2005 and 2009. Significant changes in HR-QoL scores over time were reported as mean differences with corresponding 95% CIs and concomitant P values derived from a paired two-sided Student t-test.
RESULTS

Participants.
Between 2005 and 2009, the long-term follow-up of the Dutch BOA Study was done in 482 patients (Fig 1) . Of the 165 patients alive at long-term follow-up, 123 patients completed the HR-QoL-questionnaires resulting in a response rate of 75% (Fig 2) . For the remaining 42 patients, no HR-QoL data were obtained at long-term follow-up, because 5 were lost to follow-up, 18 refused participation, 13 patients were not able to fill out the questionnaire because it was too exhausting at their advanced age, 5 patients had dementia, and 1 patient had experienced a stroke. The 123 responders were younger than the 42 nonresponders (62 and 67 years, respectively) and had fewer transient ischemic attacks or strokes at BOA study-entry (4% and 17%, respectively; Table I ). No other statistically significant differences were seen between responders and nonresponders. The mean follow-up of the 123 responders and the 42 nonresponders since randomization in BOA was 11 years.
Of the 123 responders, 53 patients completed the HR-QoL-questionnaires three times (Fig 2) . Their mean follow-up since randomization into BOA was 11 years.
The health related quality of life scores. In comparison with the norm scores of the Dutch population, both the short-term HR-QoL scores in 1001 patients and the long-term HR-QoL scores in 123 patients were lower for all health dimensions and health states, reaching statistical significance for all health dimensions and health states except for the mental health score (Table II) .
At long-term follow-up, half of the total number of responders (n ϭ 123) had experienced at least one adverse vascular event (ie, ischemic or bleeding; Fig 3, Table III ). The mean HR-QoL scores after the occurrence of an adverse vascular event were lower for all health dimensions and health states compared with the scores of responders who did not experience an adverse vascular event, reaching statistical significance for the VAS score and the physical component summary score (Fig 3) . In patients after primary bypass occlusion (n ϭ 28), a statistically significant lower score for physical functioning (44 vs 58; mean difference, 14; 95% CI, 1-27; P ϭ .030), physical role (35 vs 57; mean difference, 22; 95% CI, 3-42; P ϭ .023), and emotional role (50 vs 77; mean difference, 27; 95% CI, 7-47; P ϭ .010) were seen in comparison with the scores in patients with a patent graft (n ϭ 61). The scores for pain (59 vs 68; mean difference, 9; 95% CI, Ϫ4 to 22; P ϭ .16) and social functioning (68 vs 75; mean difference, 7; 95% CI, Ϫ6 to 20; P ϭ .30) were also lower, but without reaching statistical significance. The HR- [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , and the mean health state (0.68 vs 0.88; mean difference, 0.20; 95% CI, 0.14-0.26). Our study did not contain enough patients with a major lower limb amputation (n ϭ 11) to allow for reliable comparisons of HR-QoL scores in patients without a major amputation.
Fifty-three responders completed the HR-QoL questionnaires three times during follow-up (Fig 4) . Over time a decrease was seen for all mean HR-QoL scores, except for bodily pain, mental health, and the mental component summary score, which remained largely unchanged over time. The physical functioning score and the VAS score decreased significantly between the last patient visit for BOA and at BOA long-term follow-up (Fig 4) . Between BOA inclusion and BOA long-term follow-up, the scores for general health, physical functioning, physical component summary, emotional role, EQ-5D mean health state, and VAS decreased significantly (Fig 4) .
DISCUSSION
We have studied the change in HR-QoL over a mean period of 11 years in patients with PAD after peripheral bypass surgery. In comparison with the general population, patients with PAD have a considerably lower physical HRQoL, even if they have a patent graft and experienced no other adverse vascular events. Over time the physical HRQoL in PAD patients deteriorated further, while mental health and the perception of pain remained fairly stable. The occurrence of an adverse vascular event lowered the physical HR-QoL even more.
Our findings are in agreement with other studies. The Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program found the physical component summary score to be significantly lower in patients with PAD than in patients without PAD. 26 The mental component summary score, however, did not differ between patients with or without PAD. Corresponding results were found in the Edinburgh Artery Study, but only for patients with symptomatic PAD. 27 In patients with asymptomatic PAD the HR-QoL did not differ from patients without PAD. 27 Moreover, the HRQoL was found to decrease significantly with an increasing severity of symptomatic PAD. 17, 18, 21 The largest decrements were seen for physical functioning, social functioning, pain, and physical role. 17 The scores for mental health decreased only marginally despite PAD worsening from mild claudication to tissue loss. 17 To our knowledge, only one other study described the changes in HR-QoL in PAD patients after revascularization at long-term follow-up. 28 The HR-QoL scores significantly improved shortly after successful revascularization, as shown before in other studies, 29, 30 and remained largely unchanged up to 1 year after revascularization. However, at 4 years after revascularization physical mobility deteriorated, reaching statistical significance in patients with critical limb ischemia. Only the scores for pain remained improved up to 4 years after revascularization. 28 These observed changes in HR-QoL after revascularization corresponded well with our findings in 53 patients with three consecutive measurements over a mean period of 11 years. No clear explanation could be found for the fairly stable scores found for bodily pain and mental health, whereas the scores for the other dimensions and health states decreased over time. We assumed that perhaps coping mechanisms made the perception of pain become less pronounced over time and enables to adapt the mental health state to new conditions.
Not only does the HR-QoL deteriorate over time, but the HR-QoL also worsens substantially after the occurrence of an adverse vascular event. After a bypass occlusion a patient's physical health was lower than in patients with a patent graft, and decreased even more in patients who experienced an adverse vascular event other than bypass occlusion. Unfortunately, we were not able to distinguish the HR-QoL scores between the types of events due to too few numbers of the respective events. The patients who participated in our study were derived from the Dutch BOA Study. 6 In the Dutch BOA Study, the largest differences in health dimensions were seen after graft failure and lower limb amputation in comparison with patients without an ischemic event. 3 A symptomatic bypass occlusion or a second revascularization significantly lowered a patient's pain score and social functioning score. After a lower limb amputation, the lowest scores were reached in almost all health dimensions, especially in physical functioning, physical role, and emotional role. This finding is in line with a study that compared the HR-QoL in 130 amputees with the HR-QoL in 115 controls. 31 The amputees had significantly worse scores for all health dimensions, especially for physical health. 31 According to these results, limb salvage is important to prevent worsening of a patient's HR-QoL. Peripheral bypass surgery is able to relieve lower limb complaints and avoid amputation in the short term, but did not prove to be durable for limb salvage and HR-QoL scores. To stabilize the HR-QoL in patients with PAD as long as possible, atherosclerotic risk management through lifestyle modifications and drug treatments might be just as important as surgical intervention.
A possible limitation of our study is the relatively small number of patients with only three consecutive measure- ments of HR-QoL over time. However, at long-term follow-up a cohort of patients at high risk of vascular morbidity and mortality is expected to be small. Although a single HR-QoL measurement is sufficient to assess the HR-QoL at that moment in time, 28 -30 it would have been preferable to have smaller time intervals at which the HR-QoL was assessed for a more accurate outline of the course of the HR-QoL over time. Unfortunately, in a retrospective follow-up, this is not possible. Also, we did not inquire after other possible causes of walking disability than symptomatic PAD, such as trauma or arthritis, which could also negatively affect the physical health state. Therefore, we cannot be completely sure that the observed decrease in physical functioning is caused by the consequences of PAD only. However, we did find the physical component score to significantly decrease after a vascular event had occurred (Fig 3) , which makes the deterioration due to PAD more likely. Lastly, our long-term HR-QoL scores are probably higher than average due to survival bias, as long-term survivors probably have a better health state and thus higher HR-QoL scores compared with those who deceased. Moreover, the 123 responders probably had a better health state than the 42 nonresponders at long-term follow-up. Nevertheless, our study is the first to describe the change in the HR-QoL in patients with PAD over a mean period of 11 years after infrainguinal bypass surgery. Further prospective long-term studies in even larger populations are needed to gain insight in HR-QoL, taking the various disease states and complications that occur because of atherosclerosis into account.
CONCLUSIONS
Patients with PAD after peripheral bypass surgery have a substantially impaired HR-QoL even if their graft is patent. Over time their HR-QoL deteriorates further, mainly driven by reduced physical health. A patient's physical health worsens further after the occurrence of an adverse vascular event. This underlines the importance of secondary prevention and optimal health care in PAD patients to preserve the QOL. 
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